semaglutide for metabolic syndrome Resmetirom and in dysfunction-associated steatohepatitis (MASH): a comparative perspective Exploring beyond numeric weight loss:

Pancreatitis: Although cases of acute pancreatitis have been associated with semaglutide use, findings from the SUSTAIN 6 trial indicate a similar incidence rate of pancreatitis with semaglutide compared to the placebo group

570 Zhou, C

High-deductible plans sometimes require patients to meet annual out-of-pocket maximums before any semaglutide coverage applies, making treatment cost-prohibitive during the ramp-up phase

For those planning pregnancy, specific washout periods apply (e.g., discontinue semaglutide at least 2 months before planned conception)

mechanism of action and metabolic studies Journal of Endocrinology and Metabolism (2013) Safety and tolerability of AOD9604 in humans